Neurochemical Research

, Volume 43, Issue 12, pp 2333–2342 | Cite as

Trans-cinnamaldehyde Modulates Hippocampal Nrf2 Factor and Inhibits Amyloid Beta Aggregation in LPS-Induced Neuroinflammation Mouse Model

  • Doaa Abou El-ezzEmail author
  • Ahmed MaherEmail author
  • Nada Sallam
  • Amany El-brairy
  • Sanaa Kenawy
Original Paper


Trans-cinnamaldehyde (CNM) has recently drawn attention due to its potent anti-inflammatory and antioxidant properties. The current study explored the memory enhancing effects of CNM against lipopolysaccharide (LPS)-induced neuroinflammation in mice. CNM and curcumin (a reference antioxidant) were administered at a dose of 50 mg/kg i.p. 3 h after a single LPS injection (0.8 mg/kg, i.p.) and continued daily for 7 days. Our results displayed that CNM and curcumin significantly ameliorated the LPS-induced impairment of learning and memory, neuroinflammation, oxidative stress and neuronal apoptosis. Memory functions and locomotor activity were assessed by Morris water maze, object recognition test and open field test. Both CNM and curcumin activated the nuclear factor erythroid 2 related factor 2 (Nrf2) and restored levels of downstream antioxidant enzymes superoxide dismutase and glutathione-S-transferase (GST) in the hippocampus. They also attenuated LPS-induced increase in hippocampal contents of interleukin-1β (IL-1β), malondialdehyde and caspase-3. Immunohistochemistry results showed that both CNM and curcumin reduced Aβ1–42 protein accumulation in brain of mice. Remarkably CNM’s effect on IL-1β was less pronounced than curcumin; however it showed higher GST activity and more potent anti-apoptotic and anti-amylodogenic effect. We conclude that, CNM produces its memory enhancing effects through modulation of Nrf2 antioxidant defense in hippocampus, inhibition of neuroinflammation, apoptosis and amyloid protein burden.


Trans-cinnamaldehyde Neuroinflammation Nrf2 Curcumin LPS Amyloid beta 



The authors are grateful for Dr. Nouran Elshehaby who generously provided the Aβ1–42 antibody and Dr. Asmaa Khairy who helped with immunohistochemistry analysis.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Informed Consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Murphy GM, Yang L, Cordell B (1998) Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J Biol Chem 273:20967–20971. CrossRefPubMedGoogle Scholar
  2. 2.
    Skokowa J, Cario G, Uenalan M et al (2006) LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 12:1191–1197. CrossRefPubMedGoogle Scholar
  3. 3.
    Cunningham C (2013) Microglia and neurodegeneration: the role of systemic inflammation. Glia 61:71–90. CrossRefPubMedGoogle Scholar
  4. 4.
    Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases. Neural Regen Res 7:376–385. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mittal M, Siddiqui MR, Tran K et al (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20:1126–1167. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Spulber S, Edoff K, Hong L et al (2012) Molecular hydrogen reduces lps-induced neuroinflammation and promotes recovery from sickness behaviour in mice. PLoS ONE. CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Qin L, Wu X, Block ML et al (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55:453–462. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Maher A, El-sayed NS, Breitinger H, Zakaria M (2014) Overexpression of NMDAR2B in an inflammatory model of Alzheimer’s disease: modulation by NOS inhibitors. Brain Res Bull 109:109–116. CrossRefPubMedGoogle Scholar
  9. 9.
    Buendia I, Michalska P, Navarro E et al (2016) Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84–104. CrossRefPubMedGoogle Scholar
  10. 10.
    Magesh S, Chen Y, Hu L (2012) Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 32:687–726. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Li W, Khor TO, Xu C et al (2008) Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76:1485–1489. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen YF, Wang YW, Huang WS et al (2016) Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NFκ-B signaling pathway. NeuroMolecular Med 18:322–333. CrossRefPubMedGoogle Scholar
  13. 13.
    Kim BH, Lee YG, Lee J et al (2010) Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses. Mediators Inflamm. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Huang J, Wang S, Luo X et al (2007) Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. Thromb Res 119:337–342. CrossRefPubMedGoogle Scholar
  15. 15.
    Larasati YA, Meiyanto E (2018) Revealing the potency of cinnamon as an anti-cancer and chemopreventive agent. Indones J Cancer Chemoprev 9:47–62. CrossRefGoogle Scholar
  16. 16.
    Kim DH, Kim CH, Kim M-S et al (2007) Suppression of age-related inflammatory NF-κB activation by cinnamaldehyde. Biogerontology 8:545–554. CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang L, Zhang Z, Fu Y et al (2016) Trans-cinnamaldehyde improves memory impairment by blocking microglial activation through the destabilization of iNOS mRNA in mice challenged with lipopolysaccharide. Neuropharmacology 110:503–518. CrossRefPubMedGoogle Scholar
  18. 18.
    Goozee KG, Shah TM, Sohrabi HR et al (2015) Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease. Br J Nutr 115:449–465. CrossRefPubMedGoogle Scholar
  19. 19.
    Sharman J, Galeshi R, Onega L et al (2017) The efficacy of curcumin on cognition, depression, and agitation in older adults with Alzheimer’s disease. Open Nutr J 11:11–16. CrossRefGoogle Scholar
  20. 20.
    Kuszewski JC, Wong RHX, Howe PRC (2018) Can curcumin counteract cognitive decline? clinical trial evidence and rationale for combining ω-3 fatty acids with curcumin. Adv Nutr 9:105–113. CrossRefPubMedGoogle Scholar
  21. 21.
    Zhong W, Qian K, Xiong J et al (2016) Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling. Biomed Pharmacother 83:302–313. CrossRefPubMedGoogle Scholar
  22. 22.
    Tang M, Taghibiglou C, Liu J (2017) The mechanisms of action of curcumin in Alzheimer’s disease. J Alzheimer’s Dis 58:1003–1016. CrossRefGoogle Scholar
  23. 23.
    Roghani M, Mehraein F, Zamani M et al (2017) The effects of aqueous cinnamon bark extract and cinnamaldehyde on neurons of substantia nigra and behavioral impairment in a mouse model of Parkinson’s disease. J basic Clin Pathophysiol 5:27–32. CrossRefGoogle Scholar
  24. 24.
    Chan MM, Huang HI, Fenton MR, Fong D (1998) In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55:1955–1962. CrossRefPubMedGoogle Scholar
  25. 25.
    Pan J, Li H, Ma JF et al (2012) Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction. Transl Neurodegener 1:1–9. CrossRefGoogle Scholar
  26. 26.
    Lüesse HG, Schiefer J, Spruenken A et al (2001) Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington’s disease: behavioral testing and impact of diabetes mellitus. Behav Brain Res 126:185–195. CrossRefPubMedGoogle Scholar
  27. 27.
    Kim S-H, Han J, Seog D-H et al (2005) Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression. Life Sci 76:1297–1306. CrossRefPubMedGoogle Scholar
  28. 28.
    Nakashima Y, Ohsawa I, Konishi F et al (2009) Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice. Neurosci Lett 464:193–198. CrossRefPubMedGoogle Scholar
  29. 29.
    Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358. CrossRefPubMedGoogle Scholar
  30. 30.
    Weydert CJ, Cullen JJ (2010) Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 5:51–66. CrossRefPubMedGoogle Scholar
  31. 31.
    Asaoka K (1984) Affinity purification and characterization of glutathione S-transferases from bovine liver. J Biochem 95:685–696. CrossRefPubMedGoogle Scholar
  32. 32.
    Qu BX, Xiang Q, Li L et al (2007) Aβ42gene vaccine prevents Aβ42 deposition in brain of double transgenic mice. J Neurol Sci 260:204–213. CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Mo C, Wang L, Zhang J et al (2014) The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal 20:574–588. CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Dwivedi S, Nagarajan R, Hanif K et al (2013) Standardized extract of Bacopa monniera attenuates okadaic acid induced memory dysfunction in rats: effect on Nrf2 pathway. Evid Based Complement Altern Med. CrossRefGoogle Scholar
  35. 35.
    Rushworth SA, Chen XL, Mackman N et al (2005) Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol 175:4408–4415CrossRefGoogle Scholar
  36. 36.
    Calabrese V, Ravagna A, Colombrita C et al (2005) Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J Neurosci Res 79:509–521. CrossRefPubMedGoogle Scholar
  37. 37.
    Koh K, Cha Y, Kim S, Kim J (2009) tBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation. Biochem Biophys Res Commun 380:449–453. CrossRefPubMedGoogle Scholar
  38. 38.
    Sies H, Berndt C, Jones DP (2017) Oxidative stress. Annu Rev Biochem 86:715–748. CrossRefPubMedGoogle Scholar
  39. 39.
    Khodagholi F, Tusi SK (2011) Stabilization of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells. Mol Cell Biochem 354:97–112. CrossRefPubMedGoogle Scholar
  40. 40.
    Jawale A, Datusalia AK, Bishnoi M, Sharma SS (2016) Reversal of diabetes-induced behavioral and neurochemical deficits by cinnamaldehyde. Phytomedicine 23:923–930. CrossRefPubMedGoogle Scholar
  41. 41.
    Liu Z, Dou W, Zheng Y et al (2016) Curcumin upregulates Nrf2 nuclear translocation and protects rat hepatic stellate cells against oxidative stress. Mol Med Rep 13:1717–1724. CrossRefPubMedGoogle Scholar
  42. 42.
    Dai W, Wang H, Fang J et al (2018) Curcumin provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE signaling pathway. Brain Res Bull 140:65–71. CrossRefPubMedGoogle Scholar
  43. 43.
    González-Reyes S, Guzmán-Beltrán S, Medina-Campos ON, Pedraza-Chaverri J (2013) Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxid Med Cell Longev. CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Li W, Suwanwela NC, Patumraj S (2016) Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. Microvasc Res 106:117–127. CrossRefPubMedGoogle Scholar
  45. 45.
    Ifuku M, Katafuchi T, Mawatari S et al (2012) Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice. J Neuroinflamm 9:1–13. CrossRefGoogle Scholar
  46. 46.
    Loo DT, Copani A, Pike CJ et al (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951–7955. CrossRefPubMedGoogle Scholar
  47. 47.
    Söllvander S, Nikitidou E, Gallasch L et al (2018) The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death. J Neuroinflamm 15:98. CrossRefGoogle Scholar
  48. 48.
    Xia Z, Peng W, Cheng S et al (2017) Naoling decoction restores cognitive function by inhibiting the neuroinflammatory network in a rat model of Alzheimer’s disease. Oncotarget 8:42648–42663. CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Businaro R, Corsi M, Asprino R et al (2018) Modulation of Inflammation as a way of delaying Alzheimer’s disease progression: the diet’s role. Curr Alzheimer Res 15:363–380. CrossRefPubMedGoogle Scholar
  50. 50.
    Nesic O, Xu G-Y, McAdoo D et al (2001) IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma 18:947–956. CrossRefPubMedGoogle Scholar
  51. 51.
    Wang J, Li L, Wang Z et al (2018) Supplementation of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress. J Nutr Biochem 56:16–25. CrossRefPubMedGoogle Scholar
  52. 52.
    Poulose SM, Bielinski DF, Carey A et al (2017) Modulation of oxidative stress, inflammation, autophagy and expression of Nrf2 in hippocampus and frontal cortex of rats fed with açaí-enriched diets. Nutr Neurosci 20:305–315. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pharmacology and Toxicology, Faculty of PharmacyMSA UniversityCairoEgypt
  2. 2.Department of Biochemistry, Faculty of PharmacyMSA UniversityCairoEgypt
  3. 3.Department of Pharmacology and Toxicology, Faculty of PharmacyCairo UniversityCairoEgypt
  4. 4.Department of Physiology and Pharmacology, Cumming School of MedicineUniversity of CalgaryCalgaryCanada

Personalised recommendations